Skip to main content

Table 2 Data are mean ± SD (Standard Deviation) at T3FU and T6FU with p value

From: A double blind randomized active-controlled clinical trial on the intra-articular use of Md-Knee versus sodium hyaluronate in patients with knee osteoarthritis (“Joint”)

 

T3 FU

T6 FU

 

Group A (MD-Knee)

Group B (SUPARTZ®)

P-value

Group A (MD-Knee)

Group B (SUPARTZ®)

P-value

LKI ± SD

8.59 ± 4.71

9.79 ± 4.43

0.33

9.12 ± 3.89

9.28 ± 4.28

0.621

Pain VAS ± SD

5.26 ± 2.52

5.13 ± 2.41

NE

5.42 ± 2.69

4.43 ± 2.63

0.275

SF36 ± SD

99.15 ± 8.95

101.32 ± 6.37

NE

88.37 ± 28.83

92.07 ± 23.37

0.462

  1. NE Not evaluated
Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us